In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023
Optimizing for one drug while ignoring the rest of your medication list is how people end up surprised at the pharmacy counter in February
In a personal evaluation, your provider in Sandy, Utah, will consider your overall health and lifestyle needs to recommend the best-suited medication and navigate your insurance coverage
Each deserves examination
Patients included in the trial had HbA 1c 7-10% and were treated with either: diet and exercise alone or 1 to 3 oral antidiabetic drugs (metformin, sulfonylurea, glitazone or sodium-glucose co-transporter 2 inhibitor)